Director's Share Transfer

Futura Medical PLC
03 January 2008


For immediate release                                             3 January 2008

                               Futura Medical plc

                          ('Futura' or 'the Company')

                           Director's Share Transfer


Futura Medical plc (AIM: FUM), the pharmaceutical group that develops innovative
products for consumer healthcare, announces the following transfer of ordinary
shares in the Company by Anthony Clayden, Finance Director. There is no change
in Mr Clayden's total shareholding in the Company as a result of the transfer.

On 2 January 2008, Mr Clayden sold 30,000 ordinary shares in the Company at
45.9p a share and on the same day 30,000 ordinary shares were purchased at 46p a
share by Mr Clayden's Self Invested Personal Pension account held in a
Hargreaves Lansdown Vantage SIPP.


For further information:

Futura Medical plc
James Barder, Chief Executive                 Tel: [phone]
mail to:                                        www.futuramedical.co.uk
[e-mail]


Media enquiries:
Buchanan Communications
Mark Court / Rebecca Skye Dietrich            Tel: [phone]


Nominated Adviser:
Canaccord Adams Limited
Mark Williams / Erin Needra                   Tel: [phone]






                      This information is provided by RNS
            The company news service from the London Stock Exchange